These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. Tsugu A, Ishizaka H, Mizokami Y, Osada T, Baba T, Yoshiyama M, Nishiyama J, Matsumae M. World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963 [Abstract] [Full Text] [Related]
3. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note. Rapp M, Kamp M, Steiger HJ, Sabel M. World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813 [Abstract] [Full Text] [Related]
7. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients. Hickmann AK, Nadji-Ohl M, Hopf NJ. J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106 [Abstract] [Full Text] [Related]
8. Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study). Díez Valle R, Slof J, Galván J, Arza C, Romariz C, Vidal C, VISIONA study researchers. Neurologia; 2014 Apr; 29(3):131-8. PubMed ID: 23870657 [Abstract] [Full Text] [Related]
11. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study. da Silva EB, Vasquez MWM, de Almeida Teixeira BC, Neto MC, Sprenger F, Filho JLN, Almeida-Lopes L, Ramina R. Acta Neurochir (Wien); 2024 May 13; 166(1):212. PubMed ID: 38739282 [Abstract] [Full Text] [Related]
12. Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome. Schucht P, Seidel K, Beck J, Murek M, Jilch A, Wiest R, Fung C, Raabe A. Neurosurg Focus; 2014 Dec 13; 37(6):E16. PubMed ID: 25434385 [Abstract] [Full Text] [Related]
14. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. Feigl GC, Ritz R, Moraes M, Klein J, Ramina K, Gharabaghi A, Krischek B, Danz S, Bornemann A, Liebsch M, Tatagiba MS. J Neurosurg; 2010 Aug 13; 113(2):352-7. PubMed ID: 19911888 [Abstract] [Full Text] [Related]
15. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, ALA-Glioma Study Group. Lancet Oncol; 2006 May 13; 7(5):392-401. PubMed ID: 16648043 [Abstract] [Full Text] [Related]
18. 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature. Della Puppa A, De Pellegrin S, d'Avella E, Gioffrè G, Rossetto M, Gerardi A, Lombardi G, Manara R, Munari M, Saladini M, Scienza R. Acta Neurochir (Wien); 2013 Jun 13; 155(6):965-72; discussion 972. PubMed ID: 23468036 [Abstract] [Full Text] [Related]
19. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience. Chan DTM, Yi-Pin Sonia H, Poon WS. Asian J Surg; 2018 Sep 13; 41(5):467-472. PubMed ID: 28844780 [Abstract] [Full Text] [Related]